Spending on specialty drugs in the U.S. continues to rise each year as drugmakers focus on developing drugs to treat complex, chronic conditions.
Below is a ranking of the top 15 pharmacies generating the most revenue from dispensing specialty pharmaceuticals in 2019, according to the Drug Channels Institute.
- CVS Specialty — $43.9 billion
- Accredo/ Freedom Fertility — $32.1 billion
- AllianceRx Walgreens Prime/ Walgreens stores — $21.2 billion
- Optum Specialty Pharmacy — $17.8 billion
- Diplomat Pharmacy — $4.5 billion
- Humana Specialty Pharmacy — $3.6 billion
- Kroger Specialty Pharmacy/ Kroger stores — $3.4 billion
- Specialty Pharmacy Solutions — $1.7 billion
- US Bioservices — $1.5 billion
- AHF Pharmacy — $1.2 billion
- PANTHERx Rare — $1.2 billion
- Walmart Specialty Pharmacy — $1.1 billion
- SenderraRx — $900 million
- BioPlus Specialty Pharmacy Services — $700 million
- Onco360/ CareMed — $700 million